1)- Sarah A Morrow, Paola Kruger, Dawn Langdon, Nektaria Alexandri. What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.Neurology and therapy. 2023, 12 (5): 1419-1429
2)- Federico Carlini, Valeria Lusi, Caterina Rizzi, Francesco Assogna, Alice Laroni. Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review.Neurology and therapy. 2023, 12 (5): 1477-1490
3)- Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, Heinz Wiendl, David Paling, Mitzi Williams, Ralf Gold, Andrew Chan, Ron Milo, Ayan Das Gupta, Goeril Karlsson, Roseanne Sullivan, Gordon Graham, Martin Merschhemke, Dieter A Häring, Patrick Vermersch. The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.Neurology and therapy. 2023, 12 (5): 1491-1515
4)- Pareena Chaitanuwong, Panisa Singhanetr, Methaphon Chainakul, Niracha Arjkongharn, Paisan Ruamviboonsuk, Andrzej Grzybowski. Potential Ocular Biomarkers for Early Detection of Alzheimer's Disease and Their Roles in Artificial Intelligence Studies.Neurology and therapy. 2023, 12 (5): 1517-1532
5)- Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, Stewart J Tepper, Larry Charleston, Stephen Landy, Deena E Kuruvilla, Aubrey Manack Adams. Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.Neurology and therapy. 2023, 12 (5): 1533-1551
6)- Ziyi Shen, Nana Bao, Ming Tang, Yang Yang, Jia Li, Wei Liu, Guohui Jiang. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.Neurology and therapy. 2023, 12 (5): 1553-1572
7)- Yazan Bader, Reem Suliman, Mohamad Harb, Vanessa Santos, Ibrahim Al Qaisi, Taoufik Alsaadi. Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study.Neurology and therapy. 2023, 12 (5): 1683-1693
8)- Mei He, Wenjing Wang, Qiang He, Heling Dai, Jinming Han, Wenyao Cui. Genetic Causal Association Between the Gut Microbiome and Intracranial Aneurysm and Subarachnoid Hemorrhage: A Two-Sample Mendelian Randomization Study.Neurology and therapy. 2023, 12 (5): 1695-1707
9)- Caroline K Geiger, Danny Sheinson, Tu My To, David Jones, Nicole G Bonine. Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab.Neurology and therapy. 2023, 12 (5): 1709-1728
11)- Xing Wang, Yulu Shi, Yiyi Chen, Ying Gao, Tingting Wang, Zhengyang Li, Yilong Wang. Blood-Brain Barrier Breakdown is a Sensitive Biomarker of Cognitive and Language Impairment in Patients with White Matter Hyperintensities.Neurology and therapy. 2023, 12 (5): 1745-1758
12)- Laura Obici, Senda Ajroud-Driss, Kon-Ping Lin, John L Berk, Julian D Gillmore, Parag Kale, Haruki Koike, David Danese, Emre Aldinc, Chongshu Chen, John Vest, David Adams, . Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.Neurology and therapy. 2023, 12 (5): 1759-1775